Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: LOVELACE BIOMEDICAL RESEARCH INSTITUTE
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-09-22 to 2024-12-31
Current total value of award: $1396835.13
Description: CHARACTERIZATION OF A DOWNSTREAM GENE THERAPEUTIC FOR THE REPARATIVE TREATMENT OF SEVERE FRACTURES.